According to SNS Insider, The Genome Editing Market, valued at USD 7.99 billion in 2023 and is projected to reach USD 32.72 billion by 2032, growing at a robust CAGR of 16.98% over the forecast period from 2024 to 2032. This rapid growth is driven by significant technological advancements in gene-editing technologies, particularly CRISPR, and a rising focus on precision medicine. Genome editing applications are revolutionizing sectors such as healthcare, agriculture, and biotechnology, with increasing investments in research and development (R&D) and ongoing clinical trials.